If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,080.00    10.00 (0.93%)
Bid:
1,070.00
Ask:
1,090.00
Spread: 20.00 (1.869%)
Market Cap: £319.04m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Half Year Trading Update

19 Apr 2021 07:00

RNS Number : 7863V
Cerillion PLC
19 April 2021
 

19 April 2021

AIM: CER

 Cerillion plc

("Cerillion" or "the Company")

 

Half Year Trading Update

 

Cerillion, the billing, charging and customer relationship management software solutions provider, is pleased to announce an update on trading for the first six months of its current financial year ending 30 September 2021.

 

Cerillion has experienced its strongest ever six-month trading period, exceeding management expectations. Revenue for the first half ended 31 March 2021 is expected to total approximately £12.8m, a 25% increase on the same period last year (H1 2020: £10.2m) and adjusted EBITDA is expected to be approximately £4.8m, a 77% rise on the comparative period last year (H1 2020: £2.7m). The Company's balance sheet remains strong, with net cash at 31 March 2021 up by 60% to approximately £7.7m (31 March 2020: £4.8m).

 

This excellent performance reflects three major factors; on-going work on new customer implementation projects, strong demand from existing customers, and two major contract wins totalling £18.4m, which were secured in March 2021.

 

Reflecting the strong momentum in the business, the Company has added further resource. In addition, the Company completed Cerillion 21.1 in the period. This is the latest version of its Enterprise OSS/BSS suite for fixed, mobile, cable and multi-service operators, and will be released this month. The new release provides customers with enhanced B2B functionality, with a particular focus on lead and opportunity management.

 

Cerillion's sales pipeline remains strong, and prospects for the remainder of the financial year are very positive.

 

Notice of results

 

The Board intends to announce interim results for the six months to 31 March 2021 on 17 May 2021, when the Company will provide a further update on current trading. 

 

Louis Hall, Chief Executive of Cerillion, commented:

 

"The business has performed very strongly over the first half, and new orders in the period have equalled total new orders for the whole of the last financial year. Our last contract win represented another major milestone for us, and reflects growing market recognition of the quality of our solution and services.

 

"We have a strong pipeline of potential new business and remain well-positioned for continuing growth this financial year and next."

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

 

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Oliver Gilchrist, CFO

 

 

 

Liberum (Nomad and Broker)

T: 020 3100 2000

Bidhi Bhoma, Euan Brown, William Hall

 

 

 

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Dan Mahoney

 

 

 

 

About Cerillion

www.cerillion.com

 

Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management ("CRM"), mainly serving the telecommunications market but also other sectors such as utilities and financial services. The Company currently has over 90 customer installations across over 40 countries.

 

Headquartered in London, Cerillion also has operations in Pune, India, where its Global Solutions Centre is located, Miami and Sydney.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDZGMDDVNGMZM
Date   Source Headline
24th Sep 20078:07 amRNSAcquisition
18th Sep 20077:01 amRNSAnnouncement of Approach
14th Sep 200711:35 amRNSHolding(s) in Company
13th Sep 20073:02 pmRNSResult of AGM
12th Sep 20077:02 amRNSInterim Results
11th Sep 200712:46 pmRNSAcquisition of Option
3rd Sep 20073:16 pmRNSHolding(s) in Company
30th Aug 20079:44 amRNSHolding(s) in Company
29th Aug 20077:00 amRNSAppoints Co-Broker
23rd Aug 20071:11 pmRNSCorrected - Acquisition
23rd Aug 200712:24 pmRNSAcquisition
23rd Aug 200712:23 pmRNSAcquisition
23rd Aug 200712:22 pmRNSAcquisition
17th Aug 200711:54 amRNSAim Rule 26
15th Aug 20075:40 pmRNSHolding(s) in Company
15th Aug 20075:31 pmRNSAcquisition
15th Aug 200711:39 amRNSAGM Statement
14th Aug 20071:22 pmRNSDirector/PDMR Shareholding
14th Aug 20079:07 amRNSSeverstal strategic holding
14th Aug 20077:33 amRNSAcquisition
10th Aug 200712:15 pmRNSHolding(s) in Company
8th Aug 20077:00 amRNSHolding(s) in Company
7th Aug 20075:30 pmRNSAcquisition - SAR 6
31st Jul 200712:43 pmRNSTotal Voting Rights
31st Jul 200712:41 pmRNSHolding(s) in Company
31st Jul 20077:01 amRNSDisposal
26th Jul 200711:13 amRNSAcquisition
19th Jul 20076:00 pmRNSDirector/PDMR Shareholding
19th Jul 20075:43 pmRNSHolding(s) in Company
19th Jul 20077:00 amRNSChange of Adviser
17th Jul 20077:00 amRNSDirectorate Change
5th Jul 20075:29 pmRNSHolding(s) in Company
2nd Jul 20075:17 pmRNSDirector/PDMR Shareholding
29th Jun 200710:03 amRNSPublication of annual r&a
20th Jun 20078:31 amRNSAdditional Listing
19th Jun 20077:01 amRNSFinal Results
12th Jun 20077:00 amRNSFarm out agreement
8th Jun 200712:26 pmRNSHolding(s) in Company
30th May 20077:01 amRNSResource update
29th May 20076:19 pmRNSDirector/PDMR Shareholding
25th May 20079:56 amRNSHolding(s) in Company
24th May 20079:47 amRNSNew Molybdenum Projects
18th May 20073:22 pmRNSHolding(s) in Company
19th Apr 20074:07 pmRNSChange in director's interest
18th Apr 20077:00 amRNSTrading on PLUS
4th Apr 20075:23 pmRNSHolding in Company
20th Mar 20074:39 pmRNSDirector/PDMR Shareholding
5th Mar 20077:01 amRNS2nd joint venture agreemnt
19th Feb 20077:01 amRNSSale of Gekko Equipment
15th Feb 20077:01 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.